Latest Hemodialysis News
High-risk dialysis population also subject to the risks of long-term opioid use.
Among hemodialysis patients always or nearly always bothered by itchy skin, 17% did not report their symptoms to a health care provider and 18% used no treatment for the condition.
Despite low infection rates, AVFs have a high risk of maturation failure and abandonment.
From 2007/2008 to 2013/2014, the proportion of patients newly needing dialysis after TAVI decreased from 6.1% to 2.3%.
Except for gabapentin, evidence for 38 other treatments is weak and limited by small studies with a high risk of bias, new review finds.
VTE is more common among dialysis patients than in the general population, and the risk is highest in the first 6 months after dialysis initiation.
The odds of starting hemodialysis with an arteriovenous fistula are 31% lower for women compared with men.
High thyrotropin levels were associated with worse measures of energy/fatigue and physical functioning.
Japanese researchers conclude that a serum ferritin level below 90 ng/mL and TSAT of 20% or higher was optimal for achieving a hemoglobin level of 10 g/dL or higher.
Nearly 70% of access-related bloodstream infections occurred in hemodialysis patients with central venous catheters.
Among other changes, the new KDIGO guidelines highlight the potential dangers of hypercalcemia.
As red blood cell distribution width increases, so does the risk of death from any cause.
Patients who are readmitted within 30 days of discharge are approximately twice as likely to die in the following year.
The overall percentage of death during the one-year follow-up was 6.87%, with 64% of deaths occurring during the first 6 months.
In a study of hemodialysis patients, mortality risk increased along with phosphorus level, particularly among patients with higher residual renal urea clearance.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)